.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Dow
Healthtrust
Covington
Queensland Health
Baxter
AstraZeneca
Medtronic
Teva
Deloitte

Generated: June 25, 2017

DrugPatentWatch Database Preview

Brinzolamide - Generic Drug Details

« Back to Dashboard

What are the generic sources for brinzolamide and what is the scope of brinzolamide patent protection?

Brinzolamide
is the generic ingredient in one branded drug marketed by Novartis Pharms Corp and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for brinzolamide. One supplier is listed for this compound.

Summary for Generic Name: brinzolamide

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list10
Suppliers / Packagers: see list1
Bulk Api Vendors: see list51
Clinical Trials: see list44
Patent Applications: see list2,027
Therapeutic Class:Ophthalmic Agents
Drug Prices:see low prices
DailyMed Link:brinzolamide at DailyMed

Pharmacology for Ingredient: brinzolamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
AZOPT
brinzolamide
SUSPENSION/DROPS;OPHTHALMIC020816-001Apr 1, 1998RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: brinzolamide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
AZOPT
brinzolamide
SUSPENSION/DROPS;OPHTHALMIC020816-001Apr 1, 19985,240,923*PED► Subscribe
Novartis Pharms Corp
AZOPT
brinzolamide
SUSPENSION/DROPS;OPHTHALMIC020816-001Apr 1, 19985,461,081*PED► Subscribe
Novartis Pharms Corp
AZOPT
brinzolamide
SUSPENSION/DROPS;OPHTHALMIC020816-001Apr 1, 19985,378,703*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
McKesson
Johnson and Johnson
Covington
Fuji
Citi
US Army
Cerilliant
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot